Description: Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. The company offers products and services for the treatment of end-stage renal disease, chronic kidney disease (CKD), iron deficiency, secondary hyperparathyroidism, and hemodialysis (HD). Its products are used to cleanse patients' blood and replace nutrients lost during the kidney dialysis process. The company manufactures, sells, delivers, and distributes HD concentrates, such as CitraPure citric-acid concentrate, Dri-Sate dry acid, Renal Pure liquid acid concentrate, dry acid concentrate mixing system, RenalPure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. It also intends to offer Calcitriol, a generic active vitamin D for the treatment of secondary hyperparathyroidism in dialysis patients. In addition, the company is also developing Soluble Ferric Pyrophosphate, which is in two Phase III clinical trials for iron therapy treatment in CKD-HD patients. Rockwell Medical, Inc. sells its products directly to hemodialysis providers, as well as through independent sales agents and distributors. The company was founded in 1995 and is based in Wixom, Michigan.
Home Page: www.rockwellmed.com
RMTI Technical Analysis
30142 South Wixom road
Wixom,
MI
48393
United States
Phone:
248 960 9009
Officers
| Name | Title |
|---|---|
| Dr. Mark Strobeck Ph.D. | Pres, CEO & Director |
| Mr. Paul E. McGarry | SVP of Fin. & Chief Accounting Officer |
| Ms. Megan C. Timmins | Sr. VP, Gen. Counsel & Corp. Sec. |
| Mr. James A. McCarthy | Sr. VP of Bus. & Corp. Devel. |
| Mr. Timothy T. Chole | Sr. VP of Sales & Marketing |
| Dr. Marc L. Hoffman M.D. | Chief Medical Officer |
| Ms. Heather R. Hunter | Sr. VP & Chief Corp. Affairs Officer |
| Mr. David J. Kull | Sec. |
| Mr. Jason Finkelstein | Investor Relations Representative |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.7425 |
| Price-to-Sales TTM: | 0.1724 |
| IPO Date: | 1998-01-27 |
| Fiscal Year End: | December |
| Full Time Employees: | 300 |